New radiation method offers hope for Hard-to-Treat gynecologic cancers
NCT ID NCT06644846
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new type of radiation called spatially fractionated radiation therapy for people with cervical cancer or pelvic cancer that has come back. It is for patients who cannot get the usual brachytherapy because of unusual anatomy or large tumors. The goal is to see if this technique can control the tumor while limiting damage to nearby organs. The study will enroll 20 participants and follow them for up to 2 years.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- spatially fractionated radiation therapy
- What this could lead to
- If it works, this could offer a new radiation option for patients with cervical cancer or pelvic recurrence who cannot get standard brachytherapy.
- What could go wrong
- This is a very small early study with only 20 participants, so results may not apply broadly. The technique is new and long-term side effects are not yet known.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
ACTREC Tata Memorial Centre
RECRUITINGNavi Mumbai, Maharashtra, 410210, India
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a personalized exercise program boost recovery in cancer survivors?
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Can an antiviral make radiation more effective against cervical cancer?
- What raises endometrial cancer risk in black women? a study digs in
- A One-Two punch against cervical cancer: testing plus vaccination in HIV-Positive women
- Can a Two-Antibody combo outsmart advanced cancer?